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Abstract: Self-calcifying, self-replicating nanoparticles have been isolated from calciﬁ  ed human 
tissues. However, it is unclear if these nanoparticles participate in disease processes. Therefore, 
this study was designed to preliminarily test the hypothesis that human-derived nanoparticles 
are causal to arterial disease processes. One carotid artery of 3 kg male rabbits was denuded 
of endothelium; the contralateral artery remained unoperated as a control. Each rabbit was 
injected intravenously with either saline, calciﬁ  ed, or decalciﬁ  ed nanoparticles cultured from 
calciﬁ  ed human arteries or kidney stones. After 35 days, both injured and control arteries were 
removed for histological examination. Injured arteries from rabbits injected with saline showed 
minimal, eccentric intimal hyperplasia. Injured arteries from rabbits injected with calciﬁ  ed kidney 
stone- and arterial-derived nanoparticles occluded, sometimes with canalization. The calciﬁ  ed 
kidney stone-derived nanoparticles caused calciﬁ  cations within the occlusion. Responses to 
injury in rabbits injected with decalciﬁ  ed kidney stone-derived nanoparticles were similar to 
those observed in saline-injected animals. However, decalciﬁ  ed arterial-derived nanoparticles 
produced intimal hyperplasia that varied from moderate to occlusion with canalization and 
calciﬁ  cation. This study offers the ﬁ  rst evidence that there may be a causal relationship between 
human-derived nanoparticles and response to injury including calciﬁ  cation in arteries with 
damaged endothelium.
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Introduction
Self-replicating, self calcifying nanoparticles (NPs, formerly called nanobacteria) rang-
ing in size of 0.08–0.5 µm which form a bioﬁ  lm containing carbonate or hydroxylapatite 
have been isolated and propagated from mammalian blood (Kajander et al 1997) and 
calciﬁ  ed human arterial tissue and kidney stones (Miller et al 2004; Shiekh et al 2006). 
Although the exact nature of these nano-sized particles remains controversial, their 
propagation is reduced by certain antibiotics and inhibitors of oxidative metabolism 
(Bjorklund et al 1998; Ciftcioglu et al 2002; Kumar et al 2006). They incorporate 
radiolabeled uridine and phosphate into their structures and some sequences of nucleic 
acids have been isolated from bioﬁ  lms containing nanosized structures (Kajander et al 
1997; Cisar et al 2000; Miller et al 2004; Kumar et al 2006). Propagation seems to be 
accelerated in environments simulating microgravity (Ciftcioglu et al 2005).
In addition to calciﬁ  ed renal and arterial tissue, similar structures are found in 
human urine, renal cyst ﬂ  uid (Ciftcioglu et al 2002), capsules from breast implants 
(Deva and Chang 1999), prostatitis (Shoskes et al 2005), gall stones (Wang et al 
2006), dental plaque (Ciftcioglu et al 2003), intestinal tissue affected by inﬂ  amma-
tory bowel disease (Meissner et al 2006), and ovarian cancer (Sedivy and Battistutti 
2003). In spite of these associations, a cause and effect relationship between NPs International Journal of Nanomedicine 2008:3(2) 244
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and disease pathogenesis remains unclear. Therefore, in 
order to show a causal relationship between human-derived 
NPs and disease, Koch’s postulates dictate that particles 
(organisms) must be identiﬁ  ed in diseased tissue, isolated 
and propagated from diseased tissue, and inoculation of 
an animal with the isolates should recapitulate the disease. 
Therefore, this pilot study was designed to test the hypoth-
esis that inoculation of naïve animals with different prepa-
rations of self-replicating, self-calcifying, human-derived 
NPs would initiate disease processes, speciﬁ  cally arterial 
calciﬁ  cation, in rabbits.
Methods
Nanoparticle culture and collection
Self-replicating, self calcifying NPs derived from human 
calciﬁ  ed aortic aneurysms and kidney stones (Miller et al 
2004) were used in these experiments. NPs for injection 
were isolated from mature cultures which had formed a 
characteristic bioﬁ  lm of calciﬁ  ed domes adhering to the bot-
tom of polystyrene culture ﬂ  asks. Culture ﬂ  asks contained 
Dulbecco’s Modified Eagle Medium (DMEM 10-013, 
Mediatech Inc, Manassas, VA) supplemented with 50 µM 
beta-mercaptoethanol (Sigma Chemical Co, St. Louis, MO), 
10% γ-irradiated fetal calf serum (Atlanta Biologicals Inc, 
Lawrenceville, GA), and CaCl2 (Sigma) to 3.6 mM.
Calciﬁ  ed human-derived NPs were collected by gently 
washing 10 conﬂ  uent ﬂ  asks twice with 10 ml sterile phosphate-
buffered saline (PBS). The ﬂ  asks were scraped to loosen NP 
colonies from the ﬂ  ask and the scrapings collected and cen-
trifuged (20 min, 4 °C, 20,000 g). After each spin, tubes were 
consolidated in 0.5 ml PBS and centrifuged again. Once all 
pellets had been consolidated to a single tube, the pellet was 
washed twice with Tris buffer (10 mM) and the ﬁ  nal pellet was 
suspended in 1 ml sterile saline for injection into the animal.
Decalciﬁ  ed human-derived NPs were collected by gently 
washing 3 conﬂ  uent ﬂ  asks twice with 10 ml sterile PBS 
containing 0.5 M ethylendiaminetetraacetic acid (EDTA) 
and then adding 1 ml of 0.5 M EDTA to the ﬂ  asks for 1 
h. The ﬂ  asks were then scraped and the resulting solution 
was centrifuged (30 min, 4 °C, 60,000 g). Pellets were 
consolidated, washed, and re-suspended as described above 
for the calciﬁ  ed NPs. NPs ranged in size from 50–200 nm 
and in some situations formed clumps (please see Miller 
et al 2004).
Animals and surgery
Adult male (3 kg) New Zealand white rabbits (n = 9 total) 
were fed LabDiet hi-ﬁ  ber rabbit chow ad libitum and were 
maintained in individual cages (12 hr light/12 hr dark cycle). 
Once animals were inoculated with NPs, they were main-
tained in a Biohazard Level 2 safety facility. All protocols 
were approved by the Animal Care and Use Committee and 
Biosafety Committee of the Mayo Clinic.
The left carotid artery of each animal was denuded of 
endothelium using balloon injury. Brieﬂ  y, animals were 
sedated intramuscularly using a mixture of ketamine 
(35 mg/kg, Ketaset, Fort Dodge Animal Health, Fort Dodge, 
IA), xylazine (5 mg/kg, VetTek, Blue Springs, MO) and 
acepromazine (1 mg/kg, Boehringer Ingelheim Vetmedica 
Inc, St. Joseph, MO). They received a prophylactic dose 
of 0.25 ml penicillin (Pen-aqueous, Durvet, Inc., Blue 
Springs, MO) IM to reduce infection related to the surgery. 
This antibiotic does not interfere with NP replication in 
culture (Ciftcioglu et al 2002). Saline (60 ml, 0.9% NaCl, 
Baxter Healthcare Corp, Deerﬁ  eld, IL) was administered 
subcutaneously to prevent dehydration during the surgery. 
Using universal aseptic techniques, the left carotid artery 
was exposed and mobilized by gentle blunt dissection 
through a ventral midline incision in the neck. Small side 
branches were exposed and cauterized at least 5 mm away 
from the common carotid. Heparin (Baxter Healthcare 
Corp, Deerﬁ  eld, IL) was administered (1000 U/kg) through 
a catheter in the marginal ear vein. The carotid artery was 
then temporarily occluded proximally and distally with 
microvascular clamps.
Monoﬁ  lament suture (8–0 Ethilon; Ethicon, Somerville, 
NJ) was used to create a purse string suture in the ante-
rior region of the occluded artery. A 3.0 French Fogarty 
(Edwards Lifesciences, Irvine, CA) angioplasty catheter 
was introduced into the lumen through a small incision 
made in the center of the purse-string suture. The balloon 
was inﬂ  ated until the artery was distended to 150%. The 
catheter was withdrawn and advanced three times in order 
to denude the endothelium. The incision was closed with the 
purse-string suture. The injured area was marked by placing 
one small suture at the distal end of the artery where the 
balloon had been extended. The vascular clamps were then 
removed. The remaining carotid artery was not exposed, 
serving as the unoperated contralateral control. The surgi-
cal site was closed in three layers, the ﬁ  nal closure being 
a subcuticular stitch so that the animal could not chew the 
sutures.
Inoculation
While still under anesthesia, and within 3 hrs after the surgery, 
animals were injected with one of the following solutions International Journal of Nanomedicine 2008:3(2) 245
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(total volume of inoculant and saline washes was 5 ml) via a 
catheter placed in the marginal ear vein:
1.  Saline (Control; n = 2). This group was the standard for 
the healing response.
2. Calciﬁ  ed arterial-derived nanoparticles derived from 10 
ﬂ  asks (n = 1).
3. Calciﬁ  ed kidney stone-derived nanoparticles derived 
from 10 ﬂ  asks (n = 1).
4. Decalciﬁ  ed arterial-derived nanoparticles derived from 
three ﬂ  asks (n = 3).
5. Decalciﬁ  ed kidney stone-derived nanoparticles derived 
from three ﬂ  asks (n = 2).
Tissue collection
At 35 days post-operative, animals were anesthetized and 
carotid arteries were removed, ﬁ  xed in formalin, embedded 
in paraffin, sectioned, and examined histologically. 
Adjacent sections (5 micron) from each artery were 
evaluated by light microscopy for general anatomical 
features such as intima:media ratio, presence of a ﬁ  brous 
cap, and calciﬁ  cation using elastin van Giesen, hematoxylin 
and eosin, and von Kossa stains, respectively. Slides were 
viewed on an Axioplan 2 upright microscope equipped 
with a Plan-Neoﬂ  uar 5×, 0.15 na objective lens (Zeiss, 
Thornwood, NY). Images were digitized with an AxioCam 
HRc camera (Zeiss) mounted to the microscope with a 
0.63 × c-mount and interfaced through KS400 image 
analysis software (Zeiss). Lumen, intima, and media borders 
were interactively selected and the intimal and medial areas 
were calculated with the KS400 software.
Histological analysis
The extent of myointimal hyperplasia was evaluated based 
on intima:media ratios and a qualitative analysis of the 
condition of the internal elastic lamina and media in arterial 
cross-sections. One section per stain was evaluated from each 
animal (three sections/animal).
Results
All animals remained in good health throughout the study 
and none showed anorexia or signs of neurological deﬁ  cits 
(eye drooping, immobility, etc). The uninjured artery from 
all rabbits in all groups showed normal anatomy with a 
single layer of endothelial cells, intact internal elastic lamina 
and media, and an adventitia devoid of inﬂ  ammatory cells 
(Figure 1, upper left panel). The injured artery of animals 
injected with saline showed eccentric intimal hyperplasia 
(Figure 1, upper right panel); the intima:media ratios for the 
injured arteries from the two animals injected with saline 
were 0.39 and 1.33.
The lumen of the injured artery of each rabbit inoculated 
with calciﬁ  ed arterial- or kidney-stone-derived NPs was ﬁ  lled 
with acellular and cellular material which was canalized with 
blood vessels. The media layer lost cohesion even though 
the internal elastic lamina remained intact (Figure 1; middle 
panels).
The extent of vascular healing and intimal hyperplasia 
in injured carotid arteries of rabbits injected with decalciﬁ  ed 
arterial-derived NPs was variable. In one animal, there was 
minimal intimal hyperplasia consistent with that observed in 
the injured arteries of animals injected with saline (Figure 2, 
left panel). The art ery from another rabbit inoculated with 
decalciﬁ  ed arterial-derived NPs had greater myointimal 
hyperplasia than observed in saline-injected animals and 
the internal elastic lamina was discontinuous (Figure 2, 
middle panel). In the third rabbit injected with decalciﬁ  ed 
arterial-derived NPs, the denuded artery occluded (with 
canalization) and a plaque, which stained positive for calcium 
phosphate, formed along the intima-medial border where the 
internal elastic lamina was disrupted (Figure 2, right panel 
and Figure 1, bottom left panel). Injured arteries from the 
two animals inoculated with decalciﬁ  ed NP of kidney stone 
origin had milder injury responses similar to the two animals 
inoculated with decalciﬁ  ed NP of aneurysmal origin shown 
in the left and center panels of Figure 2.
Diffuse staining for calcium phosphate by von Kossa stain 
was identiﬁ  ed within the occluded injured artery of the animal 
injected with calciﬁ  ed NPs of kidney stone origin (Figure 1, 
lower right panel). A deﬁ  ned area of calciﬁ  cation was present 
in the occlusion of one animal injected with decalciﬁ  ed NPs 
of aneurysmal origin (Figure 1, lower left panel).
Discussion
Results of this study, while preliminary, provide the ﬁ  rst 
evidence of a causal relationship between human-derived 
NPs and arterial disease processes including accelerated 
development of intimal hyperplasia and calcification. 
Evidence has been published to support a causal relation-
ship between NPs and black pigment gall stones (Wang 
et al 2006) and renal lithogenesis (Ciftcioglu et al 2005; 
Shiekh et al 2006). However, the gall stone study utilized 
direct injection of NPs into the target organ. Intravenous 
injection of kidney-derived NPs localized to the kidney in 
the nephrolithiasis study (Shiekh et al 2006). The present 
study extends these observations to demonstrate that an 
intravenous injection of kidney stone- and arterial-derived International Journal of Nanomedicine 2008:3(2) 246
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Figure 1 Representative light micrographs of sections (5 µm) of an uninjured (upper left panel) carotid artery from a rabbit inoculated with human arterial-derived nanopar-
ticles, and the injured carotid artery of a rabbit inoculated with saline (control; upper right panel); calciﬁ  ed human arterial-derived (middle left panel) and calciﬁ  ed human kidney 
stone-derived (middle right panel and bottom right panel) nanoparticles; decalciﬁ  ed human arterial-derived nanoparticles (bottom left panel). All tissue was collected 5 weeks 
post-inoculation and sections are stained with either elastin van Giesen stain (upper and middle panels) or von Kossa stain (brown-black; lower panels). Sections are shown at 
the lowest (5X) magniﬁ  cation in order to show the entire artery. Uninjured arteries of rabbits in each treatment group are indistinguishable from that shown. Arrows indicate 
internal elastic lamina, bar indicates intimal thickening.International Journal of Nanomedicine 2008:3(2) 247
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NPs accelerates a pathological process initiated by other 
stimuli, in this case, mechanical endothelial denudation. 
This systemic exposure to NPs might be comparable to that 
resulting from an environmental exposure as could occur in 
humans. The systemic route of administration, and perhaps 
an immune response to the NPs, may explain some of the 
variability in the vascular healing response observed in 
animals inoculated with the human-derived NPs. Whether 
NPs would accelerate the response to vascular injury caused 
by other means, ie, endothelial dysfunction due to hyperlip-
idemia, remains to be determined.
Variability in vascular responses in animals exposed to 
human-derived NPs may also have resulted from the way 
inoculants were prepared. Calciﬁ  ed NPs were derived from 
combined scrapings of bioﬁ  lm from 10 ﬂ  asks and, even 
with several washing of the scraped bioﬁ  lm, some proteins 
in the culture media may remain adhered to hydroxyapatite 
shells of the NPs, initiating an immune response. Future 
experiments could investigate the contribution of inorganic 
hydroxyapatite as a carrier of mitogenic proteins and stimuli 
of inﬂ  ammation (Nadra et al 2008).
To eliminate the potential contribution of the hydroxy-
apatite shell, NPs were decalciﬁ  ed. However, variability in 
vascular remodeling was still evident. Thus, the response to 
injury observed in NP-inoculated animals does not appear 
to be mediated only by the calcium phosphate shell and/or 
nonspeciﬁ  cally associated proteins.
These experiments have several shortcomings. First, the 
number of animals in this pilot study was small. However, 
there were clear differences in responses of animals injected 
with saline compared with those injected with NPs and the 
intimal hyperplasia in saline-injected rabbits was compa-
rable with that seen in other studies of endothelial damage 
in rabbits (Orlandi et al 2002), rats (Chen and Mehta 1996), 
and pigs (Shimokawa et al 1989). Second, the inoculant was 
not standardized beyond using material initially derived 
from the same number of culture ﬂ  asks. This method 
does not take into account differences in the quality of the 
cultures or number of viable NP colonies in each ﬂ  ask. 
Differences in NP preparations could account for some of 
the variability in responses among animals. In the future, 
methods to standardize inoculants need to be developed 
including evaluating responses to free ﬂ  oating, “planktonic” 
NPs rather than those isolated from established bioﬁ  lm. 
Furthermore, complete removal of the hydroxyapatite shell 
from the decalciﬁ  ed NPs could not be veriﬁ  ed using the 
current process. Therefore, reliable methods of isolating 
or producing uncalciﬁ  ed NPs must be developed. Finally, 
it is not known whether inoculated animals developed an 
immune-type response to the NPs that would be compa-
rable to that of animals exposed to other infectious agents 
(eg, Chlamydia pneumonia cytomegalovirus) implicated 
in arterial disease (Mattila et al 1993; Muhlestein 1998; 
Epstein et al 2000; Burnett et al 2001; Muhlestein and 
Figure 2 Representative light micrographs of sections (5 µm) of injured carotid arteries of three rabbits inoculated with decalciﬁ  ed human arterial-derived nanoparticles. 
All tissue was collected 5 weeks post-inoculation and stained with an elastin van Giesen stain. Sections are shown at the lowest (5X) magniﬁ  cation in order to show the entire 
artery. Uninjured arteries in these rabbits are indistinguishable from that shown in Figure 1, upper left panel. Injured arteries from rabbits injected with decalciﬁ  ed human 
arterial-derived nanoparticles exhibited a spectrum of vascular healing, ranging from disruption of the internal elastic lamina with minimal development of intimal hyperplasia 
(left panel), disruption of the internal elastic lamina and greater intimal hyperplasia than developed in the saline-injected rabbits (middle panel), to complete occlusion with 
canalization and calciﬁ  cation (right panel). Arrows indicate internal elastic lamina, bars indicate intimal thickening.International Journal of Nanomedicine 2008:3(2) 248
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Anderson 2003). Future experiments will need to explore 
the immunological responses evoked by NPs.
In spite of these short comings, results of this study 
provide exciting proof-of-principle that human-derived, self-
replicating, self-calcifying NPs accelerate vascular wound 
healing and may lead to pathological calciﬁ  cation. Although 
the exact chemical, physical and biological nature of these 
human-derived NPs remains to be elucidated (Martin et al 
1965; Miller et al 2004; Benzerara et al 2006), these results 
support the need for ongoing investigation of the medical 
and pathophysiological consequences of NPs in humans. 
Regardless of whether or not NPs represent a pleiotropic 
form of bacteria or bioﬁ  lm (Domingue and Schlegel 1977; 
Akerman et al 1993; Domingue and Woody 1997; Costerton 
et al 1999; Cisar et al 2000; Vali et al 2001), the cumulative 
evidence from this and other studies (Shiekh et al 2006; 
Wang et al 2006) suggest that human-derived NPs partici-
pate in disease processes. Even if NPs are ultimately found 
not to be a life form in the classic sense, these experiments 
suggest a novel mechanism of disease propagation, namely 
that endogenous or exogenously derived calciﬁ  ed NPs can 
deliver pathogenic factors to a diseased segment of vessel 
and stimulate atherogenesis. Determining when and how 
humans may be exposed to these particles and the inter-
individual variability in response to such an exposure could 
signify a paradigm shift in the diagnosis and treatment of 
some diseases, including arterial calciﬁ  cation.
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